Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
EPS (Diluted)
|
Compugen Ltd
EPS (Diluted) Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
EPS (Diluted)
$0
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
2%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
EPS (Diluted)
-$9
|
CAGR 3-Years
-284%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
EPS (Diluted)
-₪5
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
See Also
What is Compugen Ltd's EPS (Diluted)?
EPS (Diluted)
-0.2
USD
-0.2
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's EPS (Diluted) amounts to -0.2 USD.
What is Compugen Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
2%
2%
Over the last year, the EPS (Diluted) growth was 46%. The average annual EPS (Diluted) growth rates for Compugen Ltd have been 17% over the past three years , 13% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
